Boris Garro

Boris Garro
Centro de Excelencia en Reumatología / Clínica De Día Jockey Salud / Clínica Delgado · Rheumatologist

Master of Business Administration

About

22
Publications
9,811
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
416
Citations
Introduction
Rheumatologist - Immunologist: ORCID: https://orcid.org/0000-0001-6137-4434 Master of Business Administration in Health Universidad de Ciencias Aplicadas (UPC) professor Principal investigator Centro de Investigación Clínica en Salud Full faculty ISCD and trainer in densitometry Nailfold Capillaroscopy trainer Centro de Excelencia en Reumatologia - CEO Biologic therapy in rheumatic diseases Osteoporosis and densitometry trainer
Additional affiliations
January 2009 - April 2016
Position
  • Researcher, Rheumatologist
May 2001 - March 2015
Clínica Ricardo Palma
Position
  • Rheumatologist
January 2001 - present
Centro de Investigación Clínica en Salud Jockey Salud
Position
  • Biologic therapy in peruvian patients with rheumatic diseases
Description
  • This will be a descriptive research about security postmarketing

Publications

Publications (22)
Presentation
Full-text available
Cambios adaptativos en el embarazo de una paciente con artritis reumatoide, dificultades en la concepción, tratamientos permitidos en la preconcepción, gestación y postgestación. Actualizada con referencias importantes.
Presentation
Full-text available
Modelo de Telesalud en el Marco de la pandemia del Covid 19, aplicable a cualquier especialidad; en este caso Telereumatología.
Article
Full-text available
Capillaroscopy is a non-invasive and safe tool which allows the evaluation of the morphology of the microcirculation. Since its recent incorporation in the 2013 American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) classification criteria for systemic sclerosis together with its assessed role to monitor disease progressi...
Article
Background: Odanacatib, a cathepsin K inhibitor, reduces bone resorption while maintaining bone formation. Previous work has shown that odanacatib increases bone mineral density in postmenopausal women with low bone mass. We aimed to investigate the efficacy and safety of odanacatib to reduce fracture risk in postmenopausal women with osteoporosis...
Conference Paper
Full-text available
Capillaroscopy: Value of this technique in the prediction of alteration of pulmonary functional tests in patients with systemic sclerosis, prediction of digital ulcers and bone quality alteration. It is a presentation within the VI International Course on Nailfold Capillaroscopy & Musculoskeletal Sonography in Rheumatic Diseases
Article
The two co-authors of the mentioned above article were incorrect. The correct are authors should have been “P. A. Beltrán” instead of “P. A. B. Roa” and “J. F. Diaz-Coto” instead of “L. Diaz Soto”.
Article
Full-text available
Introduction Biologics have improved the treatment of rheumatic diseases, resulting in better outcomes. However, their high cost limits access for many patients in both North America and Latin America. Following patent expiration for biologicals, the availability of biosimilars, which typically are less expensive due to lower development costs, pro...
Presentation
Full-text available
The most accurate diagnostic method is presented for the evauation of sarcopenia, with images and who can use this technique. ESPAÑOL Se presenta la técnica más exacta para el diagnóstico de SARCOPENIA, con imágenes, además se muestra qué personas pueden hacer uso de esta técnica
Presentation
Full-text available
What you have to know to indicate biologic therapy
Presentation
Full-text available
Respuesta a las preguntas..si una paciente con enfermedad reumática en terapia biológica pueda seguirla usando durante el embarazo. About the use of biologics (bDMARDs) in pregnancy
Presentation
Full-text available
Es posible usar medicamentos biológicos en los pacientes con enfermedades reumáticas durante el embarazo ?
Conference Paper
Background Tofacitinib is an oral JAK inhibitor for the treatment of RA. Tofacitinib can be given as monotherapy or with csDMARDs. Published data on real world (RW) tofacitinib use in Latin America (LA) are limited. We characterise the patient (pt) population starting tofacitinib and gain insights into the safety profile in the RW LA setting. Meth...
Presentation
Full-text available
This presentation is about how to recognize de injuries in sacroiliac joints by MRI in Spondyloarthritis and Ankylosing Spondylitis. Rheumatologist point of view
Presentation
Full-text available
FRAX interpretation and the consensus about Trabecular Bone Score (TBS)
Article
Full-text available
For the Pan American Health Organization (PAHO), the care of patients with chronic diseases currently experiences fragmentation in attention, generating poor performance of health services. Thus, comprehensive health care strategies arise to mitigate these problems; one of them are Centers of Excellence (CoEs), which aim to obtain high quality resu...
Presentation
Full-text available
It explains how osteoporosis is diagnosed by densitometry and the presence of vertebral fractures. The mechanism of action of new drugs in osteoporosis treatment is also explained in schemes
Presentation
Full-text available
All precautions and care they need to know before, during and after treatment with biologics is based. I show adverse events found in the first 100 patients randomly chosen found in biological therapy
Data
Full-text available
A pesar de tener un tratamiento estándar en Artritis Reumatoide, un buen grupo de pacientes no llegan a estar en remisión (ausencia de inflamación) de síntomas y siguen con la progresión del daño de sus articulaciones con el riesgo de discapacidad, incluso menor tiempo de vida. Pero la aparición de la TERAPIA BIOLÓGICA, significó un cambio de vida...
Data
Full-text available
Clinical cases with biologic therapy
Data
Full-text available
This presentation is only for personal use.
Presentation
Full-text available
It is a presentation of 2008, but completely valid

Network

Cited By